biologyhealth

New vaccine technology shows promise against Chikungunya

By 26th September 2019 September 29th, 2019 No Comments

Researchers from the University of Bristol in the UK and the French National Centre for Scientific Research (CNRS) in Grenoble, together with Oracle have teamed up to find a way to make vaccines that are thermostable and can be designed quickly. They have developed a new type of vaccine for the mosquito-borne virus Chikungunya that can be stored at warmer temperatures, removing the need for refrigeration. The technique makes use of a synthetic protein scaffold that could revolutionise the way vaccines are designed, produced and stored. The work is reported in Science Advances.

Image_1-ADDomer_Caption-Different_view_of_synthetic_multiepitope_display_scaffold_for

ADDomer: Synthetic multiepitope display scaffold for next generation vaccines
Credit: University of Bristol

Read the research paper: Synthetic self-assembling ADDomer platform for highly efficient vaccination by genetically-encoded multi-epitope display. Vragniau et alScience Advances 10.1126/sciadv.aaw2853

Read the press release from the University of Bristol.